abraxanepro.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Sitemap: | ||
Meta Tags
| Title | ABRAXANE® for Injectable Suspension | for Healthcare |
| Description | DELIVER THE BRIGHT Learn about dosing, efficacy, safety and patient financial information for ABRAXANE®. See full prescribing info and BOXED WARNINGS on |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 45.60.170.161 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
abraxanepro.com Valuation
|
US$16,362,233
Last updated: 2023-05-11 15:23:06
abraxanepro.com has Semrush global rank of 646,874. abraxanepro.com has an estimated worth of US$ 16,362,233, based on its estimated Ads revenue. abraxanepro.com receives approximately 1,887,950 unique visitors each day. Its web server is located in United States, with IP address 45.60.170.161. According to SiteAdvisor, abraxanepro.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$16,362,233 |
| Daily Ads Revenue | US$15,104 |
| Monthly Ads Revenue | US$453,108 |
| Yearly Ads Revenue | US$5,437,296 |
| Daily Unique Visitors | 125,864 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| abraxanepro.com. | A | 299 | IP: 45.60.170.161 |
| abraxanepro.com. | A | 299 | IP: 45.60.150.161 |
| abraxanepro.com. | NS | 86400 | NS Record: ns-154.awsdns-19.com. |
| abraxanepro.com. | NS | 86400 | NS Record: ns-1905.awsdns-46.co.uk. |
| abraxanepro.com. | NS | 86400 | NS Record: ns-933.awsdns-52.net. |
| abraxanepro.com. | NS | 86400 | NS Record: ns-1403.awsdns-47.org. |
| abraxanepro.com. | TXT | 300 | TXT Record: e63c83ebaa99476a8a79c90bd0cae8fb |
HtmlToTextCheckTime:2023-05-11 15:23:06
| INDICATIONS ABRAXANE ® is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated. ABRAXANE ® is indicated for the first-line treatment of locally advanced or metastatic non–small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy. ABRAXANE ® is indicated for the first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine. FULL PRESCRIBING INFORMATION INCLUDING BOXED WARNING PATIENT INFORMATION PATIENT SITES Advanced pancreatic cancer Advanced breast cancer Advanced non–small cell lung Cancer BMS ACCESS SUPPORT BMS RESOURCES THIS SITE IS INTENDED FOR U.S. HEALTHCARE PROFESSIONALS ONLY. ABOUT ABRAXANE About Home Overview Product Attributes Dosing Summary |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Fri, 05 Nov 2021 00:49:34 GMT
Content-Type: text/html; charset=iso-8859-1
Connection: keep-alive
Set-Cookie: AWSALBTG=djG1Rz8+pQ2OaLolfex2/rJXurC3v96RW/yvtM2DjlJmzpmrFP0pzg+xKfE9u7iAGa32UoQjBjQ+sdQgeNSCsNLyo/gwitlGIU2bWFrKWxbpOHDZrvcJpEQuj2MoU157g/rC5fJOISdDtqmSpB8xfLMnzFJZC94DsYrNouHElO1uwB63FWU=; Expires=Fri, 12 Nov 2021 00:49:34 GMT; Path=/
Set-Cookie: AWSALBTGCORS=djG1Rz8+pQ2OaLolfex2/rJXurC3v96RW/yvtM2DjlJmzpmrFP0pzg+xKfE9u7iAGa32UoQjBjQ+sdQgeNSCsNLyo/gwitlGIU2bWFrKWxbpOHDZrvcJpEQuj2MoU157g/rC5fJOISdDtqmSpB8xfLMnzFJZC94DsYrNouHElO1uwB63FWU=; Expires=Fri, 12 Nov 2021 00:49:34 GMT; Path=/; SameSite=None
Server: Apache
Location: https://www.abraxanepro.com/
Set-Cookie: AWSALBAPP-0=_remove_; Expires=Fri, 12 Nov 2021 00:49:34 GMT; Path=/
Set-Cookie: AWSALBAPP-1=_remove_; Expires=Fri, 12 Nov 2021 00:49:34 GMT; Path=/
Set-Cookie: AWSALBAPP-2=_remove_; Expires=Fri, 12 Nov 2021 00:49:34 GMT; Path=/
Set-Cookie: AWSALBAPP-3=_remove_; Expires=Fri, 12 Nov 2021 00:49:34 GMT; Path=/
Set-Cookie: visid_incap_2613599=QNN9S7n2RNK8d+wHaVJ4U51/hGEAAAAAQUIPAAAAAAC0ggfJSvJlgsI1HsfYGEsD; expires=Fri, 04 Nov 2022 09:46:16 GMT; HttpOnly; path=/; Domain=.abraxanepro.com
Set-Cookie: incap_ses_512_2613599=0M9RIeDESh0wEcLyy/0aB51/hGEAAAAAims44nyALpvCa1fLFO0Ylg==; path=/; Domain=.abraxanepro.com
Set-Cookie: ___utmvmBauLNzRZ=LJkNsNITWts; path=/; Max-Age=900
Set-Cookie: ___utmvaBauLNzRZ=fsLthrF; path=/; Max-Age=900
Set-Cookie: ___utmvbBauLNzRZ=nZS
XMvOyalW: MtI; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 1003-26339259-26339272 NNNN CT(22 -1 0) RT(1636073373548 2) q(0 2 2 0) r(3 3) U6
HTTP/2 200
date: Fri, 05 Nov 2021 00:49:35 GMT
content-type: text/html; charset=UTF-8
set-cookie: AWSALBTG=KPyZcCBanGhNEcU142oNUP0v3xYFI+YbNJ4dfPQ8RMEWuNnbZajGuC1v6BJnVHuzRYAiesJ9KLL1JDmRTNY3LWHZ/ZOrr+JbIsaoueY74lphunz8/iKuDx8iaGrE1VrwPQPZATHfnqP7km/3hzmdNjp+g+/pwSda17SEFxr9p2kwdvhMy3s=; Expires=Fri, 12 Nov 2021 00:49:34 GMT; Path=/
set-cookie: AWSALBTGCORS=KPyZcCBanGhNEcU142oNUP0v3xYFI+YbNJ4dfPQ8RMEWuNnbZajGuC1v6BJnVHuzRYAiesJ9KLL1JDmRTNY3LWHZ/ZOrr+JbIsaoueY74lphunz8/iKuDx8iaGrE1VrwPQPZATHfnqP7km/3hzmdNjp+g+/pwSda17SEFxr9p2kwdvhMy3s=; Expires=Fri, 12 Nov 2021 00:49:34 GMT; Path=/; SameSite=None; Secure
server: Apache
link:
|
abraxanepro.com Whois Information
Domain Name: ABRAXANEPRO.COM Registry Domain ID: 2049584239_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-08-01T05:13:42Z Creation Date: 2016-08-05T13:52:42Z Registry Expiry Date: 2022-08-05T13:52:42Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1403.AWSDNS-47.ORG Name Server: NS-154.AWSDNS-19.COM Name Server: NS-1905.AWSDNS-46.CO.UK Name Server: NS-933.AWSDNS-52.NET DNSSEC: unsigned >>> Last update of whois database: 2021-11-04T06:20:01Z <<< |